PMID: 11911367Mar 26, 2002Paper

Selection, design, and characterization of a new potentially therapeutic ribozyme

RNA
Shawn P ZinnenLeonid Beigelman

Abstract

An in vitro selection was designed to identify RNA-cleaving ribozymes predisposed for function as a drug. The selection scheme required the catalyst to be trans-acting with phosphodiesterase activity targeting a fragment of the Kras mRNA under simulated physiological conditions. To increase stabilization against nucleases and to offer the potential for improved functionality, modified sequence space was sampled by transcribing with the following NTPs: 2'-F-ATP, 2'-F-UTP, or 2'-F-5-[(N-imidazole-4-acetyl) propylamine]-UTP, 2'-NH2-CTP, and GTP. Active motifs were identified and assessed for their modified NMP and divalent metal dependence. The minimization of the ribozyme's size and the ability to substitute 2'-OMe for 2'-F and 2'-NH2 moieties yielded the motif from these selections most suited for both nuclease stability and therapeutic development. This motif requires only two 2'-NH2-Cs and functions as a 36-mer. Its substrate sequence requirements were determined to be 5'-Y-G-H-3'. Its half-life in human serum is >100 h. In physiologically relevant magnesium concentrations [approximately 1 mM] its kcat = 0.07 min(-1), Km = 70 nM. This report presents a novel nuclease stable ribozyme, designated Zinzyme, possessing optimal acti...Continue Reading

References

Oct 1, 1992·Archives of Biochemistry and Biophysics·A Romani, A Scarpa
Feb 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·D M WilliamsF Eckstein
Jan 1, 1987·Cold Spring Harbor Symposia on Quantitative Biology·D H TurnerR Kierzek
Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J A JaegerM Zuker
Jul 25, 1995·Nucleic Acids Research·F WincottN Usman
Jan 1, 1995·Annual Review of Biochemistry·B E Eaton, W A Pieken
Oct 27, 1995·The Journal of Biological Chemistry·L BeigelmanP Haeberli
Sep 5, 1995·Biochemistry·B Clouet-d'OrvalO C Uhlenbeck
Feb 7, 1995·Biochemistry·K J Hertel, O C Uhlenbeck
Nov 12, 1996·Biochemistry·A B BurginL Beigelman
Apr 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·S W Santoro, G F Joyce
Apr 1, 1997·European Journal of Biochemistry·K R BirikhF Eckstein
Sep 4, 1997·Nature·T M TarasowB E Eaton
Dec 1, 1994·Chemistry & Biology·R R Breaker, G F Joyce
Oct 1, 1995·Chemistry & Biology·R R Breaker, G F Joyce
Apr 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·N K VaishF Eckstein
May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·A Roth, R R Breaker
Jun 13, 1998·Nature Biotechnology·M Sioud, D R Sørensen
Sep 15, 1998·Biochemical and Biophysical Research Communications·M Leirdal, M Sioud
Sep 28, 1998·Biochemistry·S W Santoro, G F Joyce
Dec 16, 1998·Cellular and Molecular Life Sciences : CMLS·M Amarzguioui, H Prydz
Mar 13, 1999·Chemistry & Biology·B Seelig, A Jäschke
Jun 22, 1999·Nucleic Acids Research·T J ParryP A Pavco
Jul 17, 1999·British Journal of Cancer·M Leirdal, M Sioud
Aug 6, 1999·Antisense & Nucleic Acid Drug Development·J A SandbergT J Parry
May 10, 2000·Chemistry & Biology·A BeaudryL Beigelman
May 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·J Tang, R R Breaker
Jun 24, 2000·Bioorganic & Medicinal Chemistry Letters·J Matulic-AdamicL Beigelman
Aug 29, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P A LeeJ A Sandberg
Sep 7, 2001·Journal of the American Chemical Society·S W Santoro Barbas CF 3rd

❮ Previous
Next ❯

Citations

Apr 16, 2003·European Journal of Biochemistry·Jens Kurreck
Aug 22, 2009·Journal of Toxicology and Environmental Health. Part a·Michael J StobartJ David Knox
May 21, 2003·RNA·Denis LazarevRonald R Breaker
May 17, 2003·American Journal of Pharmacogenomics : Genomics-related Research in Drug Development and Clinical Practice·David SteeleGarrett A Soukup
Mar 9, 2004·Methods : a Companion to Methods in Enzymology·Narendra K VaishScott D Seiwert
Aug 31, 2012·Chemical Communications : Chem Comm·Vanessa SiegmundAndreas Marx
Dec 14, 2011·Chembiochem : a European Journal of Chemical Biology·Lasse H LauridsenRakesh N Veedu
Dec 19, 2014·Nucleic Acids Research·Dieter BuystAnnemieke Madder
Jul 16, 2002·Nature Biotechnology·Narendra K VaishScott D Seiwert
Oct 21, 2003·Nucleosides, Nucleotides & Nucleic Acids·Th SchoetzauS Vonhoff
Jan 13, 2018·Chemical Reviews·Alicia J AngelbelloMatthew D Disney

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.